This dual regulatory action highlights ETMEs potential as a therapeutic agent for liver inflammation (20, 21)
These symptoms could indicate infection, dehydration, or an unrelated gastrointestinal condition that requires treatment beyond GLP-1 management
*For informational purposes only
Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al
Optional maintenance: once initial goals are met, tapering dose or frequency, with periodic checkins to sustain benefits
Franchise Compliance Systems Franchise systems in the wellness industry face a particular challenge: they need to maintain brand-wide compliance standards while adapting to the varying requirements of each state where franchisees operate